130 related articles for article (PubMed ID: 23039252)
1. The rule of fives, a simple way to stratify risk for primary gastrointestinal stromal tumors (GIST).
Maki RG
Clin Sarcoma Res; 2012 Oct; 2(1):21. PubMed ID: 23039252
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
Raut CP; Espat NJ; Maki RG; Araujo DM; Trent J; Williams TF; Purkayastha DD; DeMatteo RP
JAMA Oncol; 2018 Dec; 4(12):e184060. PubMed ID: 30383140
[TBL] [Abstract][Full Text] [Related]
4. The assessment of different risk classification systems for gastrointestinal stromal tumors (GISTs): the analytic results from the SEER database.
Zhao B; Zhang J; Mei D; Zhang J; Luo R; Xu H; Huang B
Scand J Gastroenterol; 2018; 53(10-11):1319-1327. PubMed ID: 30353759
[TBL] [Abstract][Full Text] [Related]
5. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
[No Abstract] [Full Text] [Related]
6. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
[TBL] [Abstract][Full Text] [Related]
7. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
9. Retrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.
Fu Y; Hao H; Guo L; Yang G; Zhang X
Oncotarget; 2017 Feb; 8(6):10136-10144. PubMed ID: 28052037
[TBL] [Abstract][Full Text] [Related]
10. Is gastrointestinal stromal tumor (GIST) originating from the rectovaginal septum GIST or extra-GIST (EGIST)? A case report with literature review.
Lee YH; Chong GO; Hong DG
Eur J Gynaecol Oncol; 2015; 36(6):750-4. PubMed ID: 26775367
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
[No Abstract] [Full Text] [Related]
12. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
13. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
Wu X; Li J; Xu W; Gao J; Li Y; Shen L
Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant systemic therapy for small bowel gastrointestinal stromal tumor (GIST): Is there a survival benefit after R0 resection?
Patel DJ; Lutfi W; Eguia E; Sweigert P; Knab L; Abood G; Baker MS
Surgery; 2020 Oct; 168(4):695-700. PubMed ID: 32713755
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of current prognostication systems for primary gastrointestinal stromal tumors.
Khoo CY; Chai X; Quek R; Teo MCC; Goh BKP
Eur J Surg Oncol; 2018 Apr; 44(4):388-394. PubMed ID: 29422251
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
Zhang L; Cai M; Deng J; Wang X; Wang B; Liu N; Pan Y; Zhang R; Cui Q; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):331-4. PubMed ID: 24760639
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological characteristics and prognosis of patients with sporadic multiple primary gastrointestinal stromal tumors].
Wang T; Zeng XY; Yang WC; Yang M; Fan J; Jia J; Li CG; Liu WZ; Zhang P; Cai KL; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):783-788. PubMed ID: 34530559
[No Abstract] [Full Text] [Related]
18. Computed tomography in gastrointestinal stromal tumors.
Ghanem N; Altehoefer C; Furtwängler A; Winterer J; Schäfer O; Springer O; Kotter E; Langer M
Eur Radiol; 2003 Jul; 13(7):1669-78. PubMed ID: 12835984
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment Concepts.
Koumarianou A; Economopoulou P; Katsaounis P; Laschos K; Arapantoni-Dadioti P; Martikos G; Rogdakis A; Tzanakis N; Boukovinas I
Biomark Cancer; 2015; 7(Suppl 1):1-7. PubMed ID: 26056505
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal stromal tumors (GIST). Surgical therapy].
Wente MN; Büchler MW; Weitz J
Chirurg; 2008 Jul; 79(7):638-43. PubMed ID: 18575832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
